H.R.277 — Regulations from the Executive in Need of Scrutiny Act of 2023
House Roll Call
H.R.277
| Bill | H.R.277 — Regulations from the Executive in Need of Scrutiny Act of 2023 |
|---|---|
| Vote question | On Passage |
| Vote type | Yea-and-Nay |
| Result | Passed |
| Totals | Yea 221 / Nay 210 / Present 0 / Not Voting 2 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 220 | 0 | 0 | 1 |
| D | 1 | 210 | 0 | 1 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Passage
Bill Analysis
Summary of HR 277 - Regulations from the Executive in Need of Scrutiny Act of 2023
The Regulations from the Executive in Need of Scrutiny (REINS) Act of 2023 aims to enhance legislative oversight of federal regulations by requiring Congressional approval for major rules proposed by executive agencies. Specifically, the bill mandates that any rule with an economic impact exceeding $100 million, or that significantly alters the economy, must receive a vote in both the House of Representatives and the Senate before it can take effect.
Funding and Authorities: The bill does not allocate specific funding but establishes a procedural framework that requires agencies to submit major rules to Congress. This framework is designed to increase accountability and transparency in the regulatory process.
Programs or Agencies Affected: The REINS Act impacts all federal agencies that issue regulations, including but not limited to the Environmental Protection Agency (EPA), the Department of Labor (DOL), and the Food and Drug Administration (FDA). The bill aims to streamline the regulatory process by ensuring that significant rules undergo rigorous legislative scrutiny.
Beneficiaries and Regulation: The primary beneficiaries of this legislation would be businesses and industry stakeholders who seek to limit regulatory burdens. By requiring Congressional approval for major regulations, the bill seeks to provide these stakeholders with a greater voice in the regulatory process. Conversely, the bill may limit the regulatory authority of executive agencies, potentially affecting public health, safety, and environmental protections.
Key Timelines: The bill was introduced in the House and has progressed to the Senate, where it has been read a second time and placed on the Senate Legislative Calendar under General Orders as Calendar No. 103. Further action is pending, and the timeline for potential voting or amendments remains uncertain.
Overall, HR 277 represents a significant shift in the balance of power between the legislative and executive branches regarding regulatory authority.
Yea (221)
K
Kelly Armstrong
D
Dan Bishop
K
Ken Buck
L
Larry Bucshon
M
Michael Burgess
K
Ken Calvert
J
Jerry Carl
L
Lori Chavez-DeRemer
A
Anthony D'Esposito
J
John Duarte
J
Jeff Duncan
A
A. Ferguson
S
Scott Franklin
M
Matt Gaetz
M
Mike Gallagher
M
Mike Garcia
B
Bob Good
K
Kay Granger
G
Garret Graves
M
Mark Green
B
Bill Johnson
D
Doug Lamborn
J
Jake LaTurner
D
Debbie Lesko
B
Blaine Luetkemeyer
L
Lisa McClain
M
Marcus Molinaro
A
Alexander Mooney
G
Greg Pence
B
Bill Posey
C
Cathy Rodgers
M
Matthew Rosendale
J
John Rutherford
G
George Santos
D
David Schweikert
P
Pete Sessions
M
Michelle Steel
C
Chris Stewart
M
Michael Waltz
B
Brad Wenstrup
B
Brandon Williams
Nay (210)
C
Colin Allred
E
Earl Blumenauer
J
Jamaal Bowman
C
Cori Bush
Y
Yadira Caraveo
T
Tony Cárdenas
M
Matt Cartwright
G
Gerald Connolly
J
Jason Crow
L
Lloyd Doggett
A
Anna Eshoo
R
Ruben Gallego
J
John Garamendi
R
Raúl Grijalva
B
Brian Higgins
J
Jeff Jackson
S
Sheila Jackson Lee
D
Daniel Kildee
D
Derek Kilmer
A
Ann Kuster
B
Barbara Lee
K
Kathy Manning
L
Lucy McBath
G
Grace Napolitano
W
Wiley Nickel
B
Bill Pascrell
D
Donald Payne
M
Mary Peltola
D
Dean Phillips
K
Katie Porter
C
C. Ruppersberger
J
John Sarbanes
A
Abigail Spanberger
E
Eric Swalwell
R
Rashida Tlaib
D
David Trone
N
Nydia Velázquez
D
Debbie Wasserman Schultz
J
Jennifer Wexton
S
Susan Wild
Not Voting (2)
P
Patrick McHenry
